hercules glp-1 Super Support Extra Strength Capsules and healthy aging as part of a balanced lifestyle GLP-1 Protect - Therascience

Side effect management strategies backed by clinical data

doi: 10.1093/ecco-jcc/jjae160 100 SehgalPLichtensteinGRKhannaTProfkaKPickett-BlakelyONandiNet al

Dose-by-dose weight loss in Phase 2 (NEJM) Phase 2 NEJM weight loss by dose, 24 and 48 weeks Dose 1 mg 24 weeks -7.2% 48 weeks -8.7% Dose 4 mg 24 weeks -12.9% 48 weeks -17.5% Dose 8 mg 24 weeks -15.7% 48 weeks -22.8% Dose 12 mg 24 weeks -17.5% 48 weeks -24.2% Dose Placebo 24 weeks -1.6% 48 weeks -2.1% Source: Jastreboff et al., NEJM 2023

What the research shows beyond weight loss is worth understanding

There are some very clear side effects and adverse events and they occur at quite shocking rates

In the perspective, the team noted that the GLP-1RA class of medications is transforming the care of obesity and type 2 diabetes in adults and noted recent studies indicating similar powerful effects in children and adolescents